Agilent Technologies, Inc. - Diagnostics and Genomics SSEL XT2 CRE V2, 16 rxn
The Agilent SureSelect XT2 CRE V2, 16 rxn (part number 5190-9500) is a targeted enrichment solution designed for next-generation sequencing (NGS) applications. This kit enables the efficient capture and enrichment of clinically relevant exons (CRE) from genomic DNA, supporting high-throughput sequencing workflows. The XT2 chemistry provides streamlined library preparation and hybridization protocols, ensuring high specificity and uniformity of target coverage. The kit is optimized for use with Illumina sequencing platforms and is suitable for research applications requiring comprehensive analysis of clinically significant genomic regions.